文献速递关节外科创伤骨科

预测早期和晚期急性假体周围关节感染经清创、冲洗和假体保留治疗后的结局:CRIME80(慢性阻塞性肺疾病、C反应蛋白、类风湿关节炎、指数手术、男性、更换活动组件、年龄大于80岁)评分的外部验证

Predicting Outcomes of Early and Late Acute Periprosthetic Joint Infections Treated With Debridement, Irrigation, and Implant Retention: An External Validation of the CRIME80 (COPD, C-Reactive Protein, Rheumatoid Arthritis, Index Surgery, Male, Exchange of Mobile Components, Age Greater than 80 years) Score.
PubMed 文献 · J Arthroplasty · 2025-11-17

这项国际多中心回顾性验证研究纳入281例膝关节和99例髋关节急性假体周围关节感染(PJI)接受清创、抗生素和假体保留(DAIR)治疗的患者,评估CRIME80评分预测治疗失败的表现。结果显示CRIME80评分与失败呈线性趋势,但区分能力有限:髋关节PJI的AUC为0.63(95%CI 0.51至0.74),膝关节PJI的AUC为0.57(95%CI 0.51至0.64);早期急性与晚期急性感染之间无显著差异。作者结论认为CRIME80评分在临床实践中实施的价值仍不确定。

要点

  • CRIME80评分在髋关节PJI的AUC为0.63(95%CI 0.51至0.74),在膝关节PJI的AUC为0.57(95%CI 0.51至0.64),区分能力有限。
  • 早期急性感染AUC为0.62(95%CI 0.55至0.69),晚期急性感染AUC为0.55(95%CI 0.45至0.65),两者无显著差异。
  • 作者结论认为CRIME80评分在临床实践中实施的价值仍不确定。

核心结论

  • CRIME80评分预测性能有限,在髋或膝关节PJI及早期或晚期急性感染患者中结果一致,其在临床实践中实施的价值仍不确定。

研究设计与样本

  • 国际多中心验证研究,回顾性收集接受DAIR治疗的髋或膝关节急性感染患者数据,队列包括281例膝关节感染和99例髋关节感染。
  • 失败定义为:移除假体;PJI术后一年或以上需要抑制性抗生素;治疗医生确定的感染复发;初次手术后超过七天重复DAIR;或死亡。
  • 采用非参数法估计受试者工作特征曲线下面积(AUC)以评估CRIME80评分的区分性能。

主要发现

  • CRIME80评分与失败呈线性趋势,但区分性能仅为中等:髋关节PJI的AUC为0.63(95%CI 0.51至0.74),膝关节PJI的AUC为0.57(95%CI 0.51至0.64)。
  • 早期急性感染AUC为0.62(95%CI 0.55至0.69),晚期急性感染AUC为0.55(95%CI 0.45至0.65),两者无显著差异,该发现在多项敏感性分析中一致。

关键数值与推荐

  • CRIME80评分组成:慢性阻塞性肺疾病、C反应蛋白、类风湿关节炎、指数手术、男性、更换活动组件、年龄大于80岁。
  • 髋关节PJI的AUC为0.63(95%CI 0.51至0.74),膝关节PJI的AUC为0.57(95%CI 0.51至0.64)。
  • 早期急性感染AUC为0.62(95%CI 0.55至0.69),晚期急性感染AUC为0.55(95%CI 0.45至0.65)。

临床怎么用

  • 作者结论认为,鉴于CRIME80评分预测性能有限,其在临床实践中实施的价值仍不确定。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Debridement, antibiotics, and implant retention (DAIR) requires careful patient selection. The CRIME80 (COPD, C-reactive protein, Rheumatoid arthritis, Index surgery, Male, Exchange of mobile components, age greater than 80 years) score is a tool designed to predict treatment failure in patients who have late-acute PJI treated with DAIR. We aimed to assess the predictive performance of the CRIME80 score in patients who have early and late acute PJI. METHODS: We conducted an international multicenter validation study using retrospectively collected data from patients who had acute infections of the hip or knee treated with DAIR. Failure was defined as: (i) removal of the prosthesis; (ii) the need for suppressive antibiotics one or more years after surgery for PJI; (iii) relapse of infection as determined by the treating clinician; (iv) repeated DAIR more than seven days after the initial procedure; or (v) death. Nonparametric estimation of the area under the receiver operating curve (AUC) was used to establish the discriminative performance of the CRIME80 score. The cohort included 281 knee and 99 hip infections treated with DAIR. RESULTS: Although the CRIME80 score showed a linear trend with failure, the score only had modest discriminative performance (AUC in hip PJI: 0.63, 95% confidence interval (CI) 0.51 to 0.74; AUC in knee PJI: 0.57, 95% CI 0.51 to 0.64). There was no significant difference in performance in early acute (AUC: 0.62, 95% CI 0.55 to 0.69) and late acute (AUC: 0.55, 95% CI 0.45 to 0.65) infections. This finding was consistent across several sensitivity analyses. CONCLUSIONS: Our study found that the CRIME80 tool had limited predictive performance. This finding was consistent across patients who had PJI of the hip or knee and early or late acute infection. Given these findings, the benefit of implementing the CRIME80 score in clinical practice remains uncertain.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Naufal ER, Babazadeh S, Aboltins C, et al. Predicting Outcomes of Early and Late Acute Periprosthetic Joint Infections Treated With Debridement, Irrigation, and Implant Retention: An External Validation of the CRIME80 (COPD, C-Reactive Protein, Rheumatoid Arthritis, Index Surgery, Male, Exchange of Mobile Components, Age Greater than 80 years) Score. J Arthroplasty. 2025. PMID: 41260314. doi:10.1016/j.arth.2025.11.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。